Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
02/2006
02/09/2006CA2575552A1 Notch mutations leading to increased receptor signaling
02/09/2006CA2575402A1 Humanized anti-cmet antagonists
02/09/2006CA2575348A1 Novel anti-igf-ir antibodies and uses thereof
02/09/2006CA2574881A1 Antibodies to dkk-1
02/09/2006CA2574791A1 Compositions and methods of using angiopoietin-like 4 protein
02/09/2006CA2574758A1 Inhibitors of angiopoietin-like 4 protein, combinations, and their use
02/09/2006CA2574289A1 Human monoclonal antibodies against human il-4
02/09/2006CA2573864A1 Immunoglobulins comprising predominantly a glcnacman5glcnac2 glycoform
02/09/2006CA2573842A1 Immunoglobulins comprising predominantly a gal2glcnac2man3glcnac2 glycoform
02/09/2006CA2573745A1 Immunoglobulins comprising predominantly a glcnac2man3glcnac2 glycoform
02/09/2006CA2573586A1 Il-17 antagonistic antibodies
02/09/2006CA2573554A1 Immunoglobulins comprising predominantly a man5glcnac2 glycoform
02/09/2006CA2573541A1 Immunoglobulins comprising predominantly a man3glcnac2 glycoform
02/09/2006CA2573259A1 High affinity anti-tnf-alpha antibodies and method
02/09/2006CA2572618A1 Taxol immunoassay
02/09/2006CA2572602A1 Monolocal antibodies that target pathological assemblies of amyloid .beta. (abeta)
02/09/2006CA2570643A1 Interleukin-8 homologous polypeptides and therapeutic uses thereof
02/09/2006CA2568886A1 Compositions and methods for treatment of non-hodgkin's lymphoma
02/09/2006CA2568821A1 Method of diagnosing lawsonia intracellularis
02/08/2006EP1624305A1 METHOD OF MEASURING INSULIN RECEPTOR alpha SUBUNIT
02/08/2006EP1624068A1 Genetic immunization with cationic lipids
02/08/2006EP1624064A2 Nucleic acids and proteins from streptococcus pneumoniae
02/08/2006EP1624063A2 Chimeric gene encoding the antigenic determinants of four proteins of L. infantum
02/08/2006EP1624061A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/08/2006EP1623997A1 Recombinant antibodies and fragments recognising ganglioside n-glycolyl-gm3 and use thereof in the diagnosis and treatment of tumours
02/08/2006EP1623996A1 Improved method of selecting a desired protein from a library
02/08/2006EP1623990A2 Compositions and methods for the treatment of tumours
02/08/2006EP1623989A1 Compositions and methods for the diagnosis of tumours
02/08/2006EP1623229A2 Selection of b cells with specificity of interest: method of preparation and use
02/08/2006EP1623221A2 Modulators of the p2y10 receptor useful in altering t lymphocyte function
02/08/2006EP1623046A2 Compositions and methods for the treatment of severe acute respiratory syndrome (sars)
02/08/2006EP1623035A1 Avian transgenesis using a chicken ovalbumin gene region
02/08/2006EP1623016A2 Polynucleotides encoding novel variants of the trp channel family member, ltrpc3
02/08/2006EP1623011A2 IL-23p40 SPECIFIC IMMUNOGLOBULIN DERIVED PROTEINS, COMPOSITIONS, METHODS AND USES
02/08/2006EP1623006A2 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus
02/08/2006EP1622942A2 Fully human antibodies directed against the human insulin-like growth factor-1 receptor
02/08/2006EP1622941A2 Method of producing an antibody to epidermal growth factor receptor
02/08/2006EP1622938A1 Non-human animals expressing heterologous complement receptor type 1 (cr1) molecules on erythrocytes and uses therefor
02/08/2006EP1622935A2 Spex compositions and methods of use
02/08/2006EP1622933A2 H. pylori antigens
02/08/2006EP1622645A2 Compositions and methods for stem cell delivery
02/08/2006EP1622634A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
02/08/2006EP1622565A2 Method for inhibiting cellular activation by insulin-like growth factor-1
02/08/2006EP1546346A4 Embryonic stem cell markers and uses thereof
02/08/2006EP1472275A4 Protein purification
02/08/2006EP1419274A4 Modular assembly of nucleic acid-protein fusion multimers
02/08/2006EP1226176B1 Production of mammary secretion antibodies in farm animals
02/08/2006EP1112362B1 GENE MODIFICATION IN THE GENE FOR THE DIE G$g(b)3-SUB-UNIT OF HUMAN G-PROTEIN
02/08/2006EP1039933B1 METHODS AND COMPOSITIONS FOR ENHANCING IMMUNE RESPONSE AND FOR THE PRODUCTION OF $i(IN VITRO) MABS
02/08/2006EP1025230B1 ANTIBODIES, INCLUDING Fv MOLECULES, AND IMMUNOCONJUGATES HAVING HIGH BINDING AFFINITY FOR MESOTHELIN AND METHODS FOR THEIR USE
02/08/2006EP0812356B1 Prostate-specific membrane antigen and uses thereof
02/08/2006EP0783527B1 Cathepsin o2 protease
02/08/2006EP0765391B1 Cloning and expression of an acetylcholine-gated ion channel receptor subunit
02/08/2006EP0648266B1 Elicitor of the hypersensitive response in plants
02/08/2006CN1732184A Monoclonal antibody against asialo alpha 1-acid glycoprotein, immunochromatographic strip comprising the monoclonal antibody, and method for diagnosing liver diseases using the immunochromatographic s
02/08/2006CN1732016A Modified cytokines for use in cancer therapy
02/08/2006CN1732015A Low dose methods for treating disorders in which TNF-alpha activity is detrimental
02/08/2006CN1731184A A single-chain antibody method for dioxin detection
02/08/2006CN1730493A Mouse single-chain antibody of anti- nasopharyngeal carcinoma and its DNA sequence
02/08/2006CN1730492A Single-chain antibody for lactoferrin , method for making same and uses
02/08/2006CN1730490A Tumour related protein and its coding gene and uses
02/08/2006CN1729996A Process for preparing high-immune serum for main epidemic disease of dog and formulation thereof
02/08/2006CN1240836C Transforming growth factor alpha HI
02/08/2006CN1240834C LY6H gene
02/08/2006CN1240721C Conjugate of lidamycin, monoclonal antibody and its Fab'segment and its application in targeting treatment of colon cancer and other tumors
02/08/2006CN1240720C Method for separating and purifying immunoglobulin for syndrome of serious acute respiratory tract of human
02/08/2006CN1240685C Production method and use for dichloro quinolinic acid artificial hapten, artificial antigen and specific antibody
02/07/2006US6995243 A molecule of the antigen binding portion phosphoryalated at residue Ser211 or Ser226 of a specific amino acid sequence; determining glucocorticoid receptors in cells from human glucocorticoid responsive tissue; agonist screening
02/07/2006US6995241 Acute Neuronal Induced Calcium-Binding Protein (ANIC-BP-1B) polypeptides and polynucleotides; diagnostic assays; neuroprotectants; agonists; antagonists; stroke , Parkinson's disease, Alzheimer disease, multiple sclerosis and spinal cord injuries
02/07/2006US6995140 Peptides and polypeptides useful for regenerating the nervous system
02/07/2006US6995005 A cultured product, water soluble, molecular weight of 27,400 Daltons to 28,200 Daltons; polyclonal antibody, hybridoma cell produces monoclonal antibody; activating biodegradation of ester compound, polyester homo- or copolymers
02/07/2006US6994994 Of the tumor necrosis factor receptor family; given amino acid sequence; use treating diseases and disorders ameliorated or cured by decreasing the levels of ligands of the original CD40R such as autoimmune diseases
02/07/2006US6994993 Nucleotide sequences coding membrane protein for use inthe treatment of epilepsey, arrhythmia, and pain in humans
02/07/2006US6994979 Drug screening for compounds that modulate the function of anti-apoptotic protein Bcl-2 to induce apoptosis; identifying antitumor agents
02/07/2006US6994978 Human osteoclast derived cathepsin
02/07/2006US6994977 Combining a compound to be tested, a host cell expressing a recombinant protein containing a mammalian C-C chemokine receptor 3 and a ligand for binding of ligand to such receptor, detecting the formation of a receptor-ligand complex
02/07/2006US6994976 Monoclonal antibody that binds to TR3 (also known as Apo-3, DR3, LARD, Tramp, and WSL-1), a tumor necrosis factor receptor (TNFR) superfamily member of cell-surface antigens, and inhibits the proliferation of activated lymphocytes expressing TR3
02/07/2006US6994974 Drug screening for a substance that inhibits endoplasmic reticulum associated amyloid-beta peptide binding (ERAB) polypeptide from binding to amyloid-beta peptide; neurodegenerative disorders
02/07/2006US6994957 Using nucleic acid
02/07/2006US6994860 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies
02/07/2006US6994857 A Therapeutic protein (e.g., a polypeptide, antibody, or peptide, or fragments and variants) fused to albumin, is sufficient to prolong the shelf-lilfe of therapeutic protein
02/07/2006US6994856 ErbB4 receptor-specific neuregulin related ligands and uses therefor
02/07/2006US6994854 Protective epitopes of adenyl cyclase-haemolysin (AC-Hly), their application to the treatment or to the prevention of bordetella infections
02/07/2006US6994853 administering to a cancer patient in a time-staggered manner: autologous or allogeneic tumor cells of the same tumor type each treated to prevent their survival after reinfusion; and intact bispecific and/or trispecific antibodies
02/02/2006WO2006012646A2 Amacr cancer markers
02/02/2006WO2006012539A1 Contraceptives based on sp22 and sp22 antibodies
02/02/2006WO2006012508A2 Method of treating sjögren's syndrome
02/02/2006WO2006012500A2 Crystallization of antibodies or fragments thereof
02/02/2006WO2006012451A2 Compositions and methods of use for mgd-csf in disease treatment
02/02/2006WO2006012413A1 Enriched antibody for detecting mycobacterial infection, methods of use and diagnostic test employing same
02/02/2006WO2006011917A1 Method and device for detecting feline immunodeficiency virus
02/02/2006WO2005123772A3 Anti-cancer therapy
02/02/2006WO2005120222A3 Genetically modified non-human mammals and cells
02/02/2006WO2005082070A3 Compositions and methods for the systemic treatment of arthritis
02/02/2006WO2005077106A3 Monoclonal antibody based biomarker discovery and development platform
02/02/2006WO2005049635A3 Human monoclonal antibody having fat-reducing effect
02/02/2006WO2005046602A3 Vegf receptor antagonists
02/02/2006WO2005004809A3 Multivalent carriers of bi-specific antibodies
02/02/2006WO2005001038A3 Recombinant anti-cd30 antibodies and uses thereof
02/02/2006WO2003072068A3 Targeted immunotherapy of acute lymphoblastic leukemia (all)